SDC1 and mesothelioma: In order to study the relationship between VEGF, as a biomarker of tumor progression and angiogenesis, and shed SDC-1, as a biomarker of malignant effusions [21], we measured the simultaneous expression of the above markers in pleural effusion samples from mesothelioma patients.